highly significantP < 0.001
1 D, Table 2 ) and a highly significant for the recurrence-free survival ( P < 0.001, Table 2 ) in comparison with patients with stages II and III at the time of the initial diagnosis.
1 D, Table 2 ) and a highly significant for the recurrence-free survival ( P < 0.001, Table 2 ) in comparison with patients with stages II and III at the time of the initial diagnosis.